Vietnam begins human trials of Covid-19 vaccine
By Chi Le December 17, 2020 | 10:43 am GMT+7
A man is about to be injected with Nanocovax, the first made-in-Vietnam Covid-19 vaccine in Hanoi, December 17, 2020. Photo by VnExpress/Dinh Van.
Human trials of Nanocovax, the first Vietnamese Covid-19 vaccine, began on Thursday morning with the first three subjects getting shots of it.
Two men and a woman, in their 20s, whose identities were not disclosed, were vaccinated at 8:00 a.m. at the Vietnam Military Medical University in Hanoi and were in stable condition after two hours. They will be monitored for 72 hours.
They were chosen from more than 200 volunteers who had registered for the trial of the vaccine developed by Nanogen Pharmaceutical Biotechnology JSC.
Vietnam readies for Covid-19 vaccine trial
By Chi Le December 16, 2020 | 03:17 pm GMT+7
Employees of Nanogen Pharmaceutical Biotechnology JSC work in a molecular biology room to produce made-in-Vietnam vaccine to be tested on human, December 2020. Photo by VnExpress/Quynh Tran.
Vietnam will select 60 among 200 volunteers to be injected with Nanocovax, the first made-in-Vietnam Covid-19 vaccine approved for human trials, from Thursday.
Nguyen Ngo Quang, deputy head of the Administration of Science, Technology and Training under the Ministry of Health, confirmed around 200 people had signed up within a week to be vaccinated with Nanocovax, a Covid-19 vaccine developed by Nanogen Pharmaceutical Biotechnology JSC.
Wednesday, December 16, 2020, 14:31 GMT+7
A researcher at Nanogen Pharmaceutical Biotechnology implementing tests on Nanocovax, Vietnam s first homegrown COVID-19 vaccine to be approved for human trial. Photo: Duyen Phan / Tuoi Tre
Nanocovax – one of Vietnam’s domestically developed vaccines for COVID-19 – has officially received volunteers for its human clinical trial phase. Meanwhile, three other candidates are each running their own race to come up with an approved COVID-19 vaccine for mass inoculation.
Developed by Vietnamese manufacturer Nanogen Pharmaceutical Biotechnology, Nanocovax will be brought to human trials under the supervision of the Vietnam Military Medical University.
The vaccine roadmap
Just one year ago on December 3, the first case of novel coronavirus infection was detected in China. Named COVID-19, the disease stemming from the SARS-CoV-2 pathogen managed to spread across the world, causing the most contagious and precarious epidemic in the last 100
Vietnam s first coronavirus vaccine volunteer: I have faith
By Chi Le December 10, 2020 | 01:42 pm GMT+7
Minh Anh took a deep breath before signing up as Vietnam s first human subject to trial a domestic Covid-19 vaccine.
Minh Anh, 25, arrives at Vietnam Military Medical University in Hanoi to sign up for the human trial of a Vietnamese Covid-19 vaccine, December 10, 2020. Photo by VnExpress/Chi Le.
Reporting to Vietnam Military Medical University (VMMU) in Hanoi early Thursday morning, Anh, 25, agreed to become the country s first human subject for Nanocovax, a Covid-19 vaccine developed by Nanogen Pharmaceutical Biotechnology JSC.
First phase human trials would require 60 volunteers, of whom 30 had signed up as of Thursday morning at VMMU, through the phone, by email or via Nanogen s official website.